Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muir-Torre syndrome.

Giovanni Ponti1, Maurizio Ponz de Leon

  • 1Department of Internal Medicine, Division of Internal Medicine, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy.

The Lancet. Oncology
|December 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hereditary Micro‑Satellite Instable cancers associated with Lynch Syndrome: predictive biomarkers and novel immuno-therapeutic approaches.

Critical reviews in clinical laboratory sciences·2025
Same author

Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.

Critical reviews in clinical laboratory sciences·2023
Same author

Biallelic <i>PMS2</i> Mutations in a Family with Uncommon Clinical and Molecular Features.

Genes·2022
Same author

Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I.

Genes, chromosomes & cancer·2021
Same author

COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence.

Journal of clinical laboratory analysis·2021
Same author

Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients.

Clinical chemistry and laboratory medicine·2021
Same journal

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026
Same journal

Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.

The Lancet. Oncology·2026
Same journal

Co-medications and gut microbiome in NSCLC immunotherapy.

The Lancet. Oncology·2026
Same journal

Carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate.

The Lancet. Oncology·2026
Same journal

New report sheds light on cancer disparities in the USA.

The Lancet. Oncology·2026
Same journal

Review highlights gaps in South Africa's cancer care.

The Lancet. Oncology·2026
See all related articles

Muir-Torre syndrome, a genetic skin condition, presents with sebaceous tumors and is linked to internal cancers. Early diagnosis via skin lesion analysis aids in personalized screening for high-risk individuals.

Area of Science:

  • Oncology
  • Dermatology
  • Genetics

Background:

  • Muir-Torre syndrome (MTS) is an autosomal-dominant disorder characterized by sebaceous gland tumors or keratoacanthomas associated with visceral malignancies.
  • Cutaneous manifestations include sebaceous adenoma, epithelioma, carcinoma, or multiple keratoacanthomas.
  • Visceral malignancies associated with MTS encompass colorectal, endometrial, urological, and upper gastrointestinal cancers.

Purpose of the Study:

  • To elucidate the clinical and biomolecular characteristics of Muir-Torre syndrome.
  • To differentiate between the two proposed types of MTS based on mismatch repair deficiency.
  • To emphasize the importance of diagnosing rare sebaceous lesions for identifying associated internal malignancies.

Main Methods:

  • Review of clinical and biomolecular evidence for MTS.

Related Experiment Videos

  • Analysis of microsatellite instability (MSI) and immunohistochemistry (IHC) for characterizing skin lesions.
  • Correlation of cutaneous findings with visceral malignancies.

    • Main Results:

    • MTS exhibits a strong familial association with autosomal-dominant transmission, though sporadic cases occur.
    • Two types of MTS are suggested: a common variant linked to hereditary non-polyposis colorectal cancer (HNPCC) with mismatch repair gene defects, and a second type with undefined pathogenesis.
    • Diagnosis of specific sebaceous lesions necessitates a thorough search for associated internal cancers.

    Conclusions:

    • Identifying familial MTS through characteristic skin lesions and biomolecular analysis (MSI, IHC) is crucial.
    • Personalized screening programs for skin and visceral malignancies can be tailored for high-risk individuals.
    • Further research is needed to define the pathogenesis of the non-mismatch repair deficient type of MTS.